{"directed": true, "multigraph": true, "graph": {"pybel_version": "0.13.1", "document_metadata": {}, "namespace_url": {}, "namespace_pattern": {}, "namespaces_uncached": [], "annotation_url": {}, "annotation_pattern": {}, "annotation_list": {}, "path": "/Users/danieldomingo/PycharmProjects/MEN2018/curation/MAOB/MAOB.xls"}, "nodes": [{"function": "Abundance", "namespace": "MESH", "name": "C031967", "id": "a4eb2619a17220684b8024ea29e906cb4c4f6d99cd4ee3ac0dc1707f438916c0017fd8367bc52342a1d7d97d152046abf5b4748a65893fc8075a805d5958d1bf"}, {"function": "BiologicalProcess", "namespace": "GO", "name": "GO:0006915", "id": "9923d5d571c6bdea2a87c29db72af8bef2abe83d05ec53b12d9a76d309f700ea32aa8d1ec12e8afddcd6e348919e1c7629efe25cda27a670387f0e1bfb098c83"}, {"function": "BiologicalProcess", "namespace": "GO", "name": "GO:0006954", "id": "2451cdc90bea922486fd5d75027cc19e5d9bded707bc0e7fd411567a0792cfe24d5ec213a927903c101617f971a72a4d27ddde691a0aeab3f2c7f822a556cb2a"}, {"function": "BiologicalProcess", "namespace": "GO", "name": "GO:0008152", "id": "8629d0eae821ce71cdf056bff7acc78d402bd3513dfd9f1a30eef1a3bd74c6b29e3e9e25d90a34ae8ef55a34a73dd45770550df23692b4210ebaec7bedf4b963"}, {"function": "BiologicalProcess", "namespace": "GO", "name": "GO:0009056", "id": "43af78872ff3fbda19a7dc82098ac499b5faf17ef3893fcc2986e41a6fa11b497c93cb65d181b1d2b2d2163e58fa215afecfa40b9131c1bb4367ab8053a1f97e"}, {"function": "BiologicalProcess", "namespace": "GO", "name": "GO:0009058", "id": "5e90e7c0a1e7f6ebf7f8f909b8c1edbbc33405ee873cda37409a4d488b821cdefbdec54f1cbb072665ba8603fbb5345d6087aa822d8f83c4ec2d8577fc9a66d2"}, {"function": "BiologicalProcess", "namespace": "MESH", "name": "D010300", "id": "6759d95b2bc4821446ada918b675cc02533551dbdf459b775646c4923f5b2d1dd4966f87d6e19b70ae6a61e00b4b1aa6a1c8b184f9e14405354daf659d41c5c3"}, {"function": "BiologicalProcess", "namespace": "MESH", "name": "D014411", "id": "47bea34e4dabe1bf5c3b7db1ea72f9cc1fe1139363993cb49624434121887fb33a20b7cc3aa5b2923ecca4031735a81f84351a026e8c1b2e9948296cf6460575"}, {"function": "Protein", "namespace": "FPLX", "name": "ETC_complex_II", "id": "96fe80f845707198c305cfab257b0f496fb7d72ab87d44d5496fe01ccbf1992cfacb4859a22f01f403c72d594eae0587e424b66980e9b7983e924d13d698298a"}, {"function": "Protein", "namespace": "FPLX", "name": "ERK", "id": "d47253e059ce1284f4d182a53246f4d993b24c69ceb8bee74fb2a12d7d07c4a0ea65603dbb5d741283f27159ddf01ff72e2c045c05128734b83ba3ef067837b4"}, {"function": "Protein", "namespace": "FPLX", "name": "MAP1LC3", "id": "cd545dd458ffd2778f6e4bc45e6fcdbc5d948c95b2e609b5cd283ce359c2889c88d754b83c028d1ba71bb4a62e404bd045e5784dd303ecf93fb9bf23c0edf90f"}, {"function": "Protein", "namespace": "FPLX", "name": "Notch", "id": "7126deaeb2172fdf5dfac68a8ef5561baa256d78aa90f8777a80211847bc4e52ab87dfaa09a10a9a6ea5f687fbffac3154b1a3d75571469d499bf0da451ecda1"}, {"function": "Protein", "namespace": "FPLX", "name": "PDH", "id": "17ccdfc42a2f1b27bacd23b8563bb3b991c167af677913a779834c0e23fbcb42f9097114dd49e7828f7928697f2a1517560caa2cc3dc7ad18dd95010aade5289"}, {"function": "Protein", "namespace": "HGNC", "name": "AANAT", "id": "e0908de3a2427f5bea5893f9eb307ab49296a5eb847924d97746e4b47f420bd820d6911911a65caf278a5e5bff6e9c7d00ebc1e0ef7b7b2124a15d8ca61b0a46"}, {"function": "Protein", "namespace": "HGNC", "name": "ACO1", "id": "a3fd407a7d96f022279cb34cc2c055267a19a162b5b0ee37f527f5b871c8fe7cf696c8d94cb459239b1e71e36a50f063ed497b8919ddd0ec95c0c6dd22ce3af8"}, {"function": "Protein", "namespace": "HGNC", "name": "AGT", "id": "aaaccceb4e977bed82a65e2d959abe66053470a39a49bc7ab8b248e79e2cda5f9dab9a401391ebe30c0e0890f11e62a9ab7bbd99c87cdfdaf1d780038ac3acbc"}, {"function": "Protein", "namespace": "HGNC", "name": "APP", "id": "ed1d45f3255226e4210017e6c179950e0e04a300727326d7fea6a9659868e8818ff64fd5e8a2a92a703fb1566b3f48323750ac6c28e7adb40843053d276710bc"}, {"function": "Protein", "namespace": "HGNC", "name": "AR", "id": "60878547f1ea9bd206acace30325a383d895de7264633382bdeaf9a3908587be2d24d753a66f2072ea329790851aff35688463694a4afe62906b3e18e1c2d643"}, {"function": "Protein", "namespace": "HGNC", "name": "BCL2", "id": "b25decf9a9958e757d163c2d365729a1f86914126328ab0aabc90b2c29eb3a4617cd266432c4459745e2a1cd10176488cd1ba102d74f3869d82ad68257204b06"}, {"function": "Protein", "namespace": "HGNC", "name": "CPZ", "id": "4dcb8f3135070dd37cde2cc307fb5258f976b5ba2c46ddbd6060a809cc5c16b0958f2ac503f055a611f813cfb1bf794ec8f753b6c2b2222dbcd9f7310a52acd7"}, {"function": "Protein", "namespace": "HGNC", "name": "CTNND1", "id": "eb5d0a6d6f50c61a518b8ce3fcdd037ccc6fee8cfba9050450a7d7bf33d132f6a7877ee3430729b31861a2dafc8f852f5e1b5a480c34716f1e5c12e68c3c323b"}, {"function": "Protein", "namespace": "HGNC", "name": "DSP", "id": "b86d7e4b469c9bd9998bab57cb3fc4beefba5d696c684759158f43e6052b80bfbb7ecb9bee280efa5c3f0876a63a85054e468b3c11c1ed674a4b664f62e6c86a"}, {"function": "Protein", "namespace": "HGNC", "name": "EGR3", "id": "78208bb2d49ed710c1a93fd2cff55faa46b28269f8f291d2ecdf92b9bf5898343bdc715a75f0fdfa3a0539a31bba4fd6a2011667e26fdaa496832986526c2e46"}, {"function": "Protein", "namespace": "HGNC", "name": "ESRRA", "id": "842b4d73db601999045d28336a9f9afb4642006f982e3a096482607764f430f66e12e787765ec0809f6653f09169c004759a9e9be3d27ce3b636a3a829ddd070"}, {"function": "Protein", "namespace": "HGNC", "name": "FEV", "id": "b605292651a789ac5e4a00ffb5579060e7e92859c89645558e9d17975df5a52089ec78c506d0a532dcc8a4979f85a3c9afab4bc5d0d86423b9cf07539636a93c"}, {"function": "Protein", "namespace": "HGNC", "name": "FEV", "variants": [{"kind": "hgvs", "identifier": "p.?"}], "id": "84c44b07a625b0b9db2aba50c55278deefa93c96ea02988451bd9d4eb3f68d9569c4c73c16e234e82a40c56d3203b532e1ae2bd1123d1604fd7ecf5be6e89a39"}, {"function": "Protein", "namespace": "HGNC", "name": "FUT2", "id": "f90db994ec28bea4280410312015a88cf3a44b0ebabb656330698122b933ad46acdfc037d24246f339e2ed8d71e59d0807a3cfca93d1814398499fd98010ecdb"}, {"function": "Protein", "namespace": "HGNC", "name": "INS", "id": "bbf5c1f16cd0d6ad433776f0bfeca42c89fd769028501363322b16adc74541669b4a0e8ddaf039ade6e7341f046de2ad42cf1f110f16c8abd4666fd4ee201149"}, {"function": "Protein", "namespace": "HGNC", "name": "LGI1", "id": "1bfdee26706db7867387c64db15d4b40c952d102835b2dfa5d8a20e918198a0c6d393af27e2b317d9b958ba99bab86d65b91c80c7948837c804cd90df45bf5f5"}, {"function": "Protein", "namespace": "HGNC", "name": "MAOA", "id": "ca972fc1b7e044e25e421d6d974c84a19fcf68a10d5fe9b90a78c8c1499cb84ae88c9bce9ab287a05b47b57cec01eb86bfb7789d1f397e773734f2f34b4927f1"}, {"function": "Protein", "namespace": "HGNC", "name": "MAOB", "id": "5a650c9a111f35cd1a14a8715d7699e4c6df63b2ef849daff6e04bec71d9d3539393721d5126263b86620f80a503ff0155e7f8e618d8532c91e5d86ed476e64d"}, {"function": "Protein", "namespace": "HGNC", "name": "MB", "id": "44463f93d70475b746a4d4bb30fe5a64a39a98bed5e7eed1de5afe1c56910e8351bc2e83700ea5dab925cf0eb51b88d5005d54f60f26cb53824b73c2c1d8f432"}, {"function": "Protein", "namespace": "HGNC", "name": "MPZ", "id": "d76bbb7a15bc098a0415276fce2204d9f3a050339274186e73855fffd521f867c9352c83865192f383573e081fe43609951604f6e14803f279b4cf0786558a8b"}, {"function": "Protein", "namespace": "HGNC", "name": "MTR", "id": "c310c607eac8403c7ab832067d89c7cc6b1cbcad6725795b57431d31a245d003d399ab96e1d109700ed39c8195e518fc9e9b3a6ca9665902a36319aa6fa313a9"}, {"function": "Protein", "namespace": "HGNC", "name": "NALCN", "id": "d84eddd178e63f5cf24ad43b842a58a6b4b7076d4b9770e2e84dc58049641ff03e01611086928dc76891767590ecb06fd571cb4f4a969a74ea2eb78596841673"}, {"function": "Protein", "namespace": "HGNC", "name": "PRKN", "id": "c129e31246d9b635f2d39f8a0d20e11d29724b9888bc1c35e5b5f5eb721f42a8ead8ccee052e21a3c178f79c19d2fecb3360bd35d0a89f449b2d05af14ae324f"}, {"function": "Protein", "namespace": "HGNC", "name": "RENBP", "id": "0beec4d43650698860f295c8bc3ddb71b03148cc1f79fb89ff830ec3b4a458384906556d345d49508947ecf12d3bb93f5bdb4f5e2b8eed86825881bbd10204ce"}, {"function": "Protein", "namespace": "HGNC", "name": "ROS1", "id": "5b7d2d61ad2cddd181449f335f0a7a0cfec3fa455203f22b3d8ca3d8ce8cf09e236006d54b26540d38553aa2002e7a17010bab7ee148bcc12964e8f2c5f0f9db"}, {"function": "Protein", "namespace": "HGNC", "name": "SCG2", "id": "1c15ebd22f7364e6a466f0fa6ff10e0c9dd4506b3423a52e0f1cd0e3237ed68b1a1078b12b0c9dfbc09110c156ef2b38a9e0720755311e8935f7406ad3d551df"}, {"function": "Protein", "namespace": "HGNC", "name": "SMAD3", "id": "f1df97604661ba3fb80211b8bce03e38d1a54a645379df8d662a585129a7fde66297e9f4fe99c9d3af6b799df93ac7898204b802ca5aa736ca1f6bb3484cc66a"}, {"function": "Protein", "namespace": "HGNC", "name": "SNCA", "id": "4345441d1f420dc0d830377737dba9467f21b1637ed3472a697534ce698f2566b780dd52cda47c96b782242b1bcfa70e9a6147fb3bb251d1f3e1e2a0bb7038f3"}, {"function": "Protein", "namespace": "HGNC", "name": "ST3GAL4", "id": "b785374559078632cd21a76df2ab2cc45876fec3a593fe7ca2bc099cacff0548cf02216f51c69f8f4ef42cc09fed10f5c89b249cd79d0ed22013d0d69cc8a5df"}, {"function": "Protein", "namespace": "HGNC", "name": "STS", "id": "baf8b8eafb423bc4aa6ee717136d4524e324b24f8e01827793b07f280b5bc153c90e5f37a9d89043d5209327046e6e5b96cd9e5845eaa8b53439de1b0c758170"}, {"function": "Protein", "namespace": "HGNC", "name": "TNF", "id": "a262f5edbfb734dd0ec9696a3b78644fccfb4054a9cf9225beb17c33ef416a75809ff59ec1646e29a3cccc804c9294f8d2c48120af9f5ee98e764a584626426d"}, {"function": "Protein", "namespace": "HGNC", "name": "WASHC2C", "id": "35ff553319b37c6fd967efd98b3577692f6392faca0bd285f0e7144837238a4b8fd9a21bf135d4f9f40ab7c74c743065e8214acb7596a1887942d1ba594b2752"}, {"function": "Protein", "namespace": "IP", "name": "IPR006687", "id": "de5ce5019c268f3a7313cef8313de5b324c782da82f0447fa662a892082dff4c9debe6aa2b4b66333aaf4bfdd59d46402cb8fda61456a250bda2c5baa4515fa6"}, {"function": "Protein", "namespace": "PFAM", "name": "PF00668", "id": "a63d152bf4b6ba38f9a5b0a8656699f9e3912f8770bdd2f922bfbdf7ee952ddd4aea9c492029f22224d718d23cc257825398c83ab8985e6cee1675cef9ac330a"}, {"function": "Protein", "namespace": "PFAM", "name": "PF03059", "id": "e36668a68cc02d5092f4c7b820a28eed369add02abbfe3190e02c11955aca7b9e37d7e859bf5eda8a57ca89c58cbcb9fb4ba58693aa172016bf2220c488a85c8"}, {"function": "Protein", "namespace": "UP", "name": "Q06180", "id": "0fa9385015b67ba9f751d24ac9b61a8e5ea91311d97ea2a2a2b950e7cc34072d7709cb69c536e1e726d9df0f61572029897d4aea476d821ed46e6391190a5b76"}, {"function": "Protein", "namespace": "UP", "name": "Q53034", "id": "3a247da5b14ece5126be8b6ef263190f344293da2b31f469db5185f3a6b0ac6c33de0d9a77c5da1982cf5260866afae6fa59bbdc295bc6c222be5f8225577770"}, {"function": "Protein", "namespace": "UP", "name": "Q8T626", "id": "53d5d61e549d44c80786f556fd13c9131f2934699e6d0b9815fce8802b58862b08eb1822d2224093aeb8fb76712d22659572740fabf58dbcdc2c6b9e5dc33523"}], "links": [{"line": 0, "relation": "decreases", "evidence": "We compared the following drugs in the kindling model of epilepsy : 1) L-deprenyl (selegiline), i.e., an irreversible inhibitor of MAO-B, which, however, also inhibits MAO-A at higher doses, 2) the novel reversible MAO-B inhibitor LU 53439 (3,4-dimethyl-7", "citation": {"type": "PubMed", "reference": "10027835"}, "annotations": {"Curator": {"Farid": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"9331dada-49d6-479c-9a83-b5e1a94a5511": true}, "INDRA_Belief": {"0.99": true}, "INDRA_API": {"reach": true}}, "object": {"modifier": "Activity"}, "source": 30, "target": 29, "key": "23ecee1d19d141a8153043837463812c2e7f981c2d366b4bc0b7856f1f50c11faa83a26e930d6a1bf550b724f2554474543445b56f35fc2801f9fac152f17f36"}, {"line": 5, "relation": "decreases", "evidence": "When MAO-A activity was inhibited to 25% of control by clorgyline (2 mg/kg, iv) and MAO-B to 30% by deprenyl, the plasma DHPG and DOMA concentrations were reduced to 15% and 70% of controls, and to 26% and 76% of controls, respectively.", "citation": {"type": "PubMed", "reference": "11860739"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"9331dada-49d6-479c-9a83-b5e1a94a5511": true}, "INDRA_Belief": {"0.99": true}, "INDRA_API": {"reach": true}}, "object": {"modifier": "Activity"}, "source": 30, "target": 29, "key": "2b956f8a877efd3690169a2157a4b8247d4cd92f578fc2825645828c85b2a329f4e89f2a45fb5b9066f3901c612f9a99356eb130ca6cd7969df6957fe3eb1015"}, {"line": 8, "relation": "decreases", "evidence": "These data demonstrate that inhibition of MAO-A, but not MAO-B, reduces the volitional consumption of ethanol probably by preventing the formation of both biogenic aldehydes and acetaldehyde so that rewarding alkaloidal products can not be formed.", "citation": {"type": "PubMed", "reference": "12237745"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"9331dada-49d6-479c-9a83-b5e1a94a5511": true}, "INDRA_Belief": {"0.99": true}, "INDRA_API": {"reach": true}}, "object": {"modifier": "Activity"}, "source": 30, "target": 29, "key": "859cfb030eef6ca9e72d5613f0658c3d6ccfc7cc808fa375573864a91e095f9c6440daad5d588442919b4ee0c2197320dd06a80c7bf35319636d4cddd88caa16"}, {"line": 45, "relation": "decreases", "evidence": "Pharmacologic inhibition of monoamine oxidase type A (MAO-A), but not MAO-B, poses a risk of the \" cheese effect, \" a hypertensive response to excess dietary tyramine, a biogenic sympathomimetic amine.", "citation": {"type": "PubMed", "reference": "21628600"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"9331dada-49d6-479c-9a83-b5e1a94a5511": true}, "INDRA_Belief": {"0.99": true}, "INDRA_API": {"reach": true}}, "object": {"modifier": "Activity"}, "source": 30, "target": 29, "key": "b1ed6b914270f5e810141f2992f812db98ebba758bab6bc77cde415ad7503acd46058f4993e8b006bd96ed2a9377b3fac2fdb97ecddff4f3c73465bf499bda17"}, {"line": 66, "relation": "decreases", "evidence": "The advent of rasagiline enabled confirmation of the hypothesis that tyramine potentiation results from inhibition of MAO-A but not MAO-B.", "citation": {"type": "PubMed", "reference": "23908775"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"9331dada-49d6-479c-9a83-b5e1a94a5511": true}, "INDRA_Belief": {"0.99": true}, "INDRA_API": {"reach": true}}, "object": {"modifier": "Activity"}, "source": 30, "target": 29, "key": "97b3ac6109ea5f9b0b0c7156289be0b8e88501870d3999196671012afc0922921b0287ae5b7ca196dff11ea3eac9cf475314dcd55462cfd497fae4e551fe00a9"}, {"line": 1, "relation": "decreases", "evidence": "The monoamine oxidase B (MAO-B) inhibitor, (-)-deprenyl (DEP), its metabolite (-)-desmethyldeprenyl, and a tricyclic DEP analog, CGP3466, can reduce apoptosis independently of MAO-B inhibition and have been found to bind to GAPDH.", "citation": {"type": "PubMed", "reference": "10617673"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"5222fd99-3835-46c9-9abf-29112a51e8d9": true}, "INDRA_Belief": {"0.65": true}, "INDRA_API": {"reach": true}}, "source": 30, "target": 1, "key": "78be51111d95cd7a3e6d207686bd736d85af6466b79faf33867e24d5361c6aceec26c687e5c827790ea31479974a336418282e9f4709afd3ec3b7ce3180ba6ce"}, {"line": 2, "relation": "increases", "evidence": "These results show that MAO-B induces MAPK and ERK activation and cell mitogenesis through H (2) O (2) production.", "citation": {"type": "PubMed", "reference": "10777699"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"e1fba84f-5bd5-4e84-a8de-6a76b73164df": true}, "INDRA_Belief": {"0.65": true}, "INDRA_API": {"reach": true}}, "object": {"modifier": "Activity"}, "source": 30, "target": 9, "key": "ed098c085ebfc844d21d8337e42ab51a70dbe3bbc6efc1e43307c8200434779e31b66750c88dadc510b529d8557cd84fee6ee3b63617cc9542ac144ded90a884"}, {"line": 4, "relation": "decreases", "evidence": "The infarct volumes in the cortex or in the striatum did not differ between the experimental groups 72 hr after transient occlusion of the middle cerebral artery, which suggests that during ischaemia/reperfusion, suppressed oxidative stress by partial MAO", "citation": {"type": "PubMed", "reference": "11129505"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"eddf810f-698b-4ecd-80c2-8bad7841d1d2": true}, "INDRA_Belief": {"0.65": true}, "INDRA_API": {"sparser": true}}, "object": {"modifier": "Activity"}, "source": 30, "target": 28, "key": "3a2efa11937d5e9d33806d70d281529416df8f9488c5a1d50ac461a0fc1703753aed18fa4ede8d452d50091fd5217c99a4249f571df030884f510684f6968cf0"}, {"line": 9, "relation": "decreases", "evidence": "Inhibitors of monoamine oxidase A (MAO-A) but not MAO-B stimulate the activity of pineal serotonin N-acetyltransferase (AANAT) in the adult rat pineal leading to increased formation of N-acetyl serotonin (NAS) and melatonin (MEL).", "citation": {"type": "PubMed", "reference": "12404611"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"4ad19c64-bbc1-49ac-b2af-94d2f758c834": true}, "INDRA_Belief": {"0.65": true}, "INDRA_API": {"reach": true}}, "object": {"modifier": "Activity"}, "source": 30, "target": 13, "key": "66a49d2628708a87b3431f3ae7d7b3062280c5d578376c03d24d05658ba1f10db2555ab6f945b5bc90912e19abaa9975224e760faa0ba73c24d7c2fc41e95e27"}, {"line": 13, "relation": "increases", "evidence": "It has been suggested that polymorphisms in monoamine oxidase B (MAOB) and catechol-O-methyltransferase (COMT) might increase the risk of PD.", "citation": {"type": "PubMed", "reference": "15753616"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"9b1b2974-a6b1-4262-a316-c26a079cff87": true}, "INDRA_Belief": {"0.94": true}, "INDRA_API": {"reach": true}}, "source": 30, "target": 6, "key": "067f5cde63584b3e356788df9b5b87dad4849514ac56a28c25b4eb1601eb2858cfd683c117b7c885d602650cd3ee3300c9508603b49b32370c893df23a9ff847"}, {"line": 23, "relation": "increases", "evidence": "Our data demonstrates that elevation of murine astrocytic MAO-B by itself can induce several phenotypes of PD, signifying that MAO-B could be directly involved in multiple aspects of disease neuropathology.", "citation": {"type": "PubMed", "reference": "18286173"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"9b1b2974-a6b1-4262-a316-c26a079cff87": true}, "INDRA_Belief": {"0.94": true}, "INDRA_API": {"reach": true}}, "source": 30, "target": 6, "key": "a6d23a4954bd60b529e2b0a129deefeb253626d27babb8ce4fddeec5c9022816f6545183c1967383476e823a01d29d22da776c8ddd63c978443cd0a3832208b2"}, {"line": 22, "relation": "decreases", "evidence": "Elevation in astrocytic MAO-B results in increased conversion of MPTP to MPP + and significant increases in toxin induced dopaminergic SN cell loss.", "citation": {"type": "PubMed", "reference": "18286173"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"d2eb1b00-098f-4d64-b94e-6af44349152e": true}, "INDRA_Belief": {"0.65": true}, "INDRA_API": {"reach": true}}, "object": {"modifier": "Activity"}, "source": 30, "target": 38, "key": "985eda515b6dfecaaeb208ded11c438ba576aec656af34d68abe0a76868c75c81917772aabc38102f0434ab7d6929b18ea541ba60609672ee935c1a9debbbdad"}, {"line": 25, "relation": "increases", "evidence": "Interestingly, siRNA mediated gene silencing of MAOB in cells reduces Abeta production, but not Notch processing.", "citation": {"type": "PubMed", "reference": "18358303"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"7d82731f-b8fe-4307-9d65-50d165de4730": true}, "INDRA_Belief": {"0.95": true}, "INDRA_API": {"reach": true}}, "object": {"modifier": "Activity"}, "source": 30, "target": 16, "key": "ab0eeefb6a6872ecb1b21eb0398b723dd972dc96e96e5a355dc215eac7066118cd4db5c9e54433e58b03d868f037fbe885c76435f7dc091d94821d4679ad7761"}, {"line": 27, "relation": "increases", "evidence": "siRNA experiments showed that reduced levels of MAOB resulted in reduced Abeta production, with only minor effects on the release of Notch intracellular domain (manuscript in preparation).", "citation": {"type": "PubMed", "reference": "18358303"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"7d82731f-b8fe-4307-9d65-50d165de4730": true}, "INDRA_Belief": {"0.95": true}, "INDRA_API": {"reach": true}}, "object": {"modifier": "Activity"}, "source": 30, "target": 16, "key": "67f1024a69b3d14ae498262d496f8507f129b97ec19e8a1fe49d8892619ae843fe20609a29df1cea10b2f67e970828a7f527eee84e472853eb3805afbd1ed5af"}, {"line": 26, "relation": "increases", "evidence": "Interestingly, siRNA mediated gene silencing of MAOB in cells reduces Abeta production, but not Notch processing.", "citation": {"type": "PubMed", "reference": "18358303"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"fca75618-c720-4d82-8112-76183263112a": true}, "INDRA_Belief": {"0.65": true}, "INDRA_API": {"reach": true}}, "object": {"modifier": "Activity"}, "source": 30, "target": 11, "key": "4beebbeae60fe670f7ecc13523f4b995c52357f59fd9eb972667df6efeff6089cb7db570e0c08796ce94590f00e1dd34e899df56d6a0e07c78af985fd3b1f2d9"}, {"line": 29, "relation": "association", "evidence": "Inhibition of MAO-B activity using the selective inhibitor PF9601N did not reduce this cryolesion induced inflammatory response.", "citation": {"type": "PubMed", "reference": "18831059"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"cb83add5-a502-4b59-8d00-7129c3fd0c19": true}, "INDRA_Belief": {"0.65": true}, "INDRA_API": {"reach": true}}, "source": 30, "target": 2, "key": "55a8dea90ac9ff30b3026a8baec2777c3b8dbc30b90a6d2d805d7a9400e1800d76c37c458205932fad5976c5519cc4c95d3829b3be69acd03496c29c44a3964c"}, {"line": 31, "relation": "decreases", "evidence": "MAO-B elevation was found to substantially inhibit mitochondrial aconitase, KGDH, complex I, succinate dehydrogenase, and PDH activities to an extent ranging from 33.5% to nearly 60%; these inhibitions were deprenyl sensitive and prevented by catalase pre", "citation": {"type": "PubMed", "reference": "19526285"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"fd1570e0-dc65-44fc-b9a0-a3e663e1d4c5": true}, "INDRA_Belief": {"0.65": true}, "INDRA_API": {"reach": true}}, "object": {"modifier": "Activity"}, "source": 30, "target": 14, "key": "7661f99ffbf25d55f5d5b4d366a1fb8ee30551fccb8b3fbfa3a1673dcd35d01b5cc34c29883155d14413ab24cf51cf4ff6b597279f3d7dc81c94dc8595dd5928"}, {"line": 32, "relation": "decreases", "evidence": "MAO-B elevation was found to substantially inhibit mitochondrial aconitase, KGDH, complex I, succinate dehydrogenase, and PDH activities to an extent ranging from 33.5% to nearly 60%; these inhibitions were deprenyl sensitive and prevented by catalase pre", "citation": {"type": "PubMed", "reference": "19526285"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"1e9affb2-579c-4cf1-b86c-89789e9950bd": true}, "INDRA_Belief": {"0.65": true}, "INDRA_API": {"reach": true}}, "object": {"modifier": "Activity"}, "source": 30, "target": 8, "key": "d5948de3e561a21a2d123c5f65f6fe5ef34c803aa17874dd2c3c69cf4cb03352911e6f46ef94addcfc2a7a112766e3ada338b6a9ec492f299f08ed3bc60a2c6a"}, {"line": 33, "relation": "decreases", "evidence": "MAO-B elevation was found to substantially inhibit mitochondrial aconitase, KGDH, complex I, succinate dehydrogenase, and PDH activities to an extent ranging from 33.5% to nearly 60%; these inhibitions were deprenyl sensitive and prevented by catalase pre", "citation": {"type": "PubMed", "reference": "19526285"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"8a87c8fc-88b0-4529-8bf2-add3c81d6727": true}, "INDRA_Belief": {"0.65": true}, "INDRA_API": {"reach": true}}, "object": {"modifier": "Activity"}, "source": 30, "target": 12, "key": "15557eb0a8a78735153970394bc985d35eb97ec3543d00e3bb4acc888c3e6efe9abe3d0e994b85b2fe77f6927238554b5df20f3105c49cf9b487a50a6e6448d0"}, {"line": 36, "relation": "increases", "evidence": "These results suggest that LPS induces chronic wounds via elevated MAO/B mediated increases in H (2) O (2) and TNF-alpha activity by epithelial cells and is further associated with more distant effects on systemic oxidative stress and alveolar bone loss.", "citation": {"type": "PubMed", "reference": "19779138"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"70d701bc-ae6f-4887-952f-712d09d0e34d": true}, "INDRA_Belief": {"0.65": true}, "INDRA_API": {"reach": true}}, "object": {"modifier": "Activity"}, "source": 30, "target": 43, "key": "25952b382ba265df269c72d9809a7ac78bfa006c6d269000da0053e6c607b5fba8523a8028fabc41936e799bc7b7729d9ae1cd7d7082ed2059633c7e525dee5d"}, {"line": 39, "relation": "increases", "evidence": "The cause for this transient decrease in activity is not clear however MAO-B mediated increases in ROS could result in elevated levels of endogenous oxidized indoles such as isatin which are known inhibitors of MAO-B activity [XREF_BIBR].", "citation": {"type": "PubMed", "reference": "20655384"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"a30d76a6-7b6f-44e4-bdd7-b8ab463c4c28": true}, "INDRA_Belief": {"0.98": true}, "INDRA_API": {"reach": true}}, "object": {"modifier": "Activity"}, "source": 30, "target": 37, "key": "0284bbc99b476f713bf2ab60de7e0fc67ce84268637b750f60f828f2592a849d31c7f8bf7069303513bba1821e93a478768e9d16422ab06d09bb8713d2a8156f"}, {"line": 40, "relation": "increases", "evidence": "The fact that dox removal at day 3 was able to halt further MAO-B increases in ROS levels as well as subsequent neuropathological events including loss of CI activity and nigrostriatal neurodegeneration suggests that oxidative stress may contribute to the", "citation": {"type": "PubMed", "reference": "20655384"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"75bfe11f-5ac8-4edd-9fcc-36c30611639e": true}, "INDRA_Belief": {"0.65": true}, "INDRA_API": {"reach": true}}, "source": 30, "target": 37, "key": "fdde5468930b9a004f2ba44b83e39c7daf91064dd4b197ceccc2a9e8de245041079867eca30d96b44e29453cf0d35d0a1aedf179b980c27dd733455e95e0dc1a"}, {"line": 54, "relation": "increases", "evidence": "xREF_BIBR, XREF_BIBR In the brain, metabolism of escitalopram propionate may be mediated by MAO-A, MAO-B, and aldehyde oxidase.", "citation": {"type": "PubMed", "reference": "22329629"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"a30d76a6-7b6f-44e4-bdd7-b8ab463c4c28": true}, "INDRA_Belief": {"0.98": true}, "INDRA_API": {"reach": true}}, "object": {"modifier": "Activity"}, "source": 30, "target": 37, "key": "6b567bff56789e2b0aca598ad20e9ff4133a524699929edb15c528f9b5a1f75170172d596fb2aff5d5b5a8ca8cdaed6fe0054d7c708d000f8fbe355ec430e548"}, {"line": 55, "relation": "increases", "evidence": "MAO-B catalysed ROS production has also been suggested to contribute to age related increases in mitochondrial damage, particularly in the substantia nigra (SN), a brain region, which displays preferential neurodegeneration in PD [XREF_BIBR].", "citation": {"type": "PubMed", "reference": "22329629"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"a30d76a6-7b6f-44e4-bdd7-b8ab463c4c28": true}, "INDRA_Belief": {"0.98": true}, "INDRA_API": {"reach": true}}, "object": {"modifier": "Activity"}, "source": 30, "target": 37, "key": "8586050eb085de4c512a8f70c61987d86b998df7b03f5e34584df87197b38851a47b42c30466ac863c05e2d624dd8bb5415e1d0bcd48f9d57cd70c53e3a5ed62"}, {"line": 41, "relation": "increases", "evidence": "XREF_BIBR, XREF_BIBR In the brain, metabolism of escitalopram propionate may be mediated by MAO-A, MAO-B, and aldehyde oxidase.", "citation": {"type": "PubMed", "reference": "20856599"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"f5d99288-8b43-4db3-9aec-0c7bd729b086": true}, "INDRA_Belief": {"0.95": true}, "INDRA_API": {"reach": true}}, "source": 30, "target": 3, "key": "4d56b64c5f30b56c2a5f67502e5175f2dda380084ae565b975ae479b46e668f1b60324afb7cb206ce2b09bf35d9509aca260036e090ef3941dfefa4bc21c4e2c"}, {"line": 46, "relation": "increases", "evidence": "L-DOPA has been hypothesized to enhance neurodegeneration [XREF_BIBR] since DA metabolism by MAO-B generates ROS [XREF_BIBR].", "citation": {"type": "PubMed", "reference": "21722346"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"f5d99288-8b43-4db3-9aec-0c7bd729b086": true}, "INDRA_Belief": {"0.95": true}, "INDRA_API": {"reach": true}}, "source": 30, "target": 3, "key": "65acaa856691b44d8f992e200db4fbf26d9d857a5bb6159fc44be86053e2be5a8af03a18b633dfad9392390c28d9ea16b7e070105dd2aa74e4104fe1dca66cee"}, {"line": 68, "relation": "increases", "evidence": "The products of MAO-B mediated metabolism of dopamine are 3,4-dihydroxyphenyl-acetaldehyde, an ammonium molecule and H 2 O 2.", "citation": {"type": "PubMed", "reference": "24252804"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"f5d99288-8b43-4db3-9aec-0c7bd729b086": true}, "INDRA_Belief": {"0.95": true}, "INDRA_API": {"reach": true}}, "source": 30, "target": 3, "key": "72469b03727152b1f9236a3b2ce6dcd920af4408e8b28f4fe04a13cc0b8b63f0f6fd1a4535703cdc2e7e0064d2fe406b23712b1f29947700e84bc3079d983139"}, {"line": 42, "relation": "increases", "evidence": "Additionally these model examinations provide evidence that oxidations of N-cyclopropyl derivatives of MPTP catalyzed by MAO-B may not be consistent with a pure SET pathway.", "citation": {"type": "PubMed", "reference": "21277784"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"d78d55d7-9439-48fd-a4fc-28138efeeb50": true}, "INDRA_Belief": {"0.86": true}, "INDRA_API": {"reach": true}}, "object": {"modifier": "Activity"}, "source": 30, "target": 48, "key": "1f4433e5864f0b4078de1caee1b6d56a9c841b861831bd406adc59262650229ef12b7c0771d8b3f5ff8192dd117390387df5ae91964e58f43a9d7480239a35c6"}, {"line": 43, "relation": "increases", "evidence": "In addition, it is suggested that the conversion from MPTP to MPP (+) is caused mainly by MAO-B located in ependymal cells and GFAP positive cells in the SVZ.", "citation": {"type": "PubMed", "reference": "21324658"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"5ef9c119-32f5-4f6d-a692-c4968a4df5ef": true}, "INDRA_Belief": {"0.86": true}, "INDRA_API": {"reach": true}}, "object": {"modifier": "Activity"}, "source": 30, "target": 32, "key": "b8d3e7ee59fcf642d7481c0a2e96ed2d2721c2f898b2549ce9b5138acf61b3e87891e5930bc738a14110d20a929f3676486f50219a1234ea6981012d8ffc582d"}, {"line": 44, "relation": "decreases", "evidence": "The primary difference between early and advanced patients is that when used as monotherapy for early PD, MAO-B inhibitors are primarily acting on endogenous dopamine, whereas those with advanced PD and combination therapy are deriving benefits from MAO-B", "citation": {"type": "PubMed", "reference": "21423589"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"d6ae0921-c645-491e-bbed-7e78d5b6b8de": true}, "INDRA_Belief": {"0.65": true}, "INDRA_API": {"reach": true}}, "source": 30, "target": 4, "key": "63ea1bc146bdebdda113905c04181748037935b8f7b3d967f7f7883117e1aedc67b393983c9ec6a2c93c3f979e711156eb87893ce77f8773a2236cb6645ce2ef"}, {"line": 50, "relation": "increases", "evidence": "MAO-B increases in the ventral midbrain of Smad3 null mice.", "citation": {"type": "PubMed", "reference": "21995845"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"39b51bce-b1c6-4a09-b0bc-5765a337b548": true}, "INDRA_Belief": {"0.65": true}, "INDRA_API": {"reach": true}}, "object": {"modifier": "Activity"}, "source": 30, "target": 39, "key": "6b3f3e8bbbcb4e32d08e214b5fea63fffec0289e61705fc10b093193d2498416052c74708a65ff7fe2674baa9dd2868cc2ec73a3f6185a4e9b040f06e2b116a0"}, {"line": 51, "relation": "decreases", "evidence": "MAO-B overexpression inhibited Bcl-2 induction by rasagiline and befloxatone, but did not affect that by (-) deprenyl, suggesting the different mechanisms behind Bcl-2 gene induction by these MAO-B inhibitors.", "citation": {"type": "PubMed", "reference": "22065207"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"cb1741d2-d384-4ab1-877c-f349e9cacae2": true}, "INDRA_Belief": {"0.65": true}, "INDRA_API": {"reach": true}}, "object": {"modifier": "Activity"}, "source": 30, "target": 18, "key": "bf4fa2643e86bd43d82e27af7fba275b9a4f38c733bf74c4283b265953c4f24261b8f4465ddca6e193d4dcff702f01dda0513210da257ee80bcdc70568b47819"}, {"line": 56, "relation": "decreases", "evidence": "Our experiments demonstrated a decrease in LC3 following induction of human MAO-B expression, suggesting decreased efficiency of autophagic degradation (XREF_FIG).", "citation": {"type": "PubMed", "reference": "22329629"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"105a9825-9be8-4514-b361-70a281929a69": true}, "INDRA_Belief": {"0.65": true}, "INDRA_API": {"reach": true}}, "source": 30, "target": 10, "key": "e97d8992447d16ad50e7428c525fe27b88720bcc557304c328a8111aee436aac29792b5198271410c4be1d9f1c2878f42ae7e302834b51f4a8e8f0e6aced80ba"}, {"line": 62, "relation": "decreases", "evidence": "Acute administration of MAO-B type inhibitor, deprenyl (not exerting an antidepressant effect), did not stimulate rat pineal NAS biosynthesis.", "citation": {"type": "PubMed", "reference": "23514379"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"03817f03-65f7-40e2-99ce-33033fce75db": true}, "INDRA_Belief": {"0.65": true}, "INDRA_API": {"reach": true}}, "object": {"modifier": "Activity"}, "source": 30, "target": 47, "key": "a68ed7e9df1e56122e007c47859ba498214ff3b7ca1fc64cf1abdaebff17ace8939655fd7c9cdf84e83e8dae4f5e77421d6e35d8cbf0df0e906bdd205afcda62"}, {"line": 63, "relation": "decreases", "evidence": "Acute administration of MAO-B type inhibitor, deprenyl (not exerting an antidepressant effect), did not stimulate rat pineal NAS biosynthesis.", "citation": {"type": "PubMed", "reference": "23514379"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"f1adb70b-0d3a-473e-80f6-a789eaedf1f7": true}, "INDRA_Belief": {"0.65": true}, "INDRA_API": {"reach": true}}, "source": 30, "target": 5, "key": "a181a55d69a488d194e077767d156bd75e4833fd2978a415f66e2b0c3b9360a1de08e3638fe263e372128e32df16cbb1535d50e928a42d9d83aa7b2a520f0a09"}, {"line": 64, "relation": "increases", "evidence": "This property of selegiline, together with observation that the basal ganglia of human brain possessed predominantly MAO-B that could metabolize dopamine led us to initiate a pilot study with selegiline in Parkinson 's disease [XREF_BIBR].", "citation": {"type": "PubMed", "reference": "23585716"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"6f51de22-0acd-47da-a29f-df3286b3c2b0": true}, "INDRA_Belief": {"0.65": true}, "INDRA_API": {"reach": true}}, "object": {"modifier": "Activity"}, "source": 30, "target": 22, "key": "dce5d9d85dc7efe10cb86f1ce463029f0334fafa6b713623e569896739ba78bd343075d6d2550a9e41c349c954fe6fb9baa6211dec452e349dbdc0e74bafc862"}, {"line": 73, "relation": "increases", "evidence": "MAOB was the common targets of both AR and RR.", "citation": {"type": "PubMed", "reference": "24598793"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"2cdceaf9-b4e7-475f-872e-f0edda543b21": true}, "INDRA_Belief": {"0.65": true}, "INDRA_API": {"reach": true}}, "object": {"modifier": "Activity"}, "source": 30, "target": 17, "key": "87850e10ba756b2f80ffd98467cfc6c5901d9e3be4b69c1585998f0667041db9e817188489bd86e183a187521431066acb2b779d33ba1976add218db8b78dffa"}, {"line": 17, "relation": "decreases", "evidence": "At the same doses, liver and striatum MAO-A was less inhibited in vivo, somehow reflecting MAO-B selectivity, as assessed in vitro.", "citation": {"type": "PubMed", "reference": "17193252"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"771a378d-7ef9-4874-bc85-64ceeb5c0e63": true}, "INDRA_Belief": {"0.99": true}, "INDRA_API": {"reach": true}}, "object": {"modifier": "Activity"}, "source": 29, "target": 30, "key": "fa47f872f22980e09792eb13745b25ebe4b58bd12334e9cc6a71219825cf47bb0c8701f82ae3dd55d3a3f8999cbfb3eaefc362537bb229834bb754f78cc7beaa"}, {"line": 37, "relation": "decreases", "evidence": "The MAO-A subtype which selectively degrades 5-HT and MAO-B which degrades dopamine have been localized to 5-HT neurons.", "citation": {"type": "PubMed", "reference": "20554102"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"771a378d-7ef9-4874-bc85-64ceeb5c0e63": true}, "INDRA_Belief": {"0.99": true}, "INDRA_API": {"reach": true}}, "object": {"modifier": "Activity"}, "source": 29, "target": 30, "key": "2f1db9af02b634cd1c47d91c7c03ca30ba2d07635aa3903f2af5090d59fa6378d80b1c8aaaa912a66b366ad399a12c8713c7debf1dbc73452abadc1a626bea8b"}, {"line": 3, "relation": "decreases", "evidence": "The question may arise as to whether monoamine oxidase A inhibition or monoamine oxidase B inhibition (or both) by non-selective monoamine oxidase inhibitors contributes to reducing conditioned freezi[MISSING/INVALID API KEY: limited to 200 char for Elsev", "citation": {"type": "PubMed", "reference": "11040348"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"160efbea-5dcc-4b90-95df-a17aefd626a0": true}, "INDRA_Belief": {"0.86": true}, "INDRA_API": {"sparser": true}}, "object": {"modifier": "Activity"}, "source": 34, "target": 30, "key": "fccc6f4ed65324c70178408af8f7944a94eb245aff8ff3aeb9d1fa286ebcf9d7fcfd34c2579461297568020548dc64b953949dec6699f3eef77d5ab0fc024015"}, {"line": 30, "relation": "decreases", "evidence": "Tobacco smoke contains chemicals that inhibit MAOA, xref â€“ xref and brain MAOA levels are reduced in smokers.  xref  Simultaneous, irreversible inhibition of both MAOA and MAOB by non-selective MAOA/B inhibitors (for example, tranylcypromine or phenelzi", "citation": {"type": "PubMed", "reference": "19238150"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"160efbea-5dcc-4b90-95df-a17aefd626a0": true}, "INDRA_Belief": {"0.86": true}, "INDRA_API": {"sparser": true}}, "object": {"modifier": "Activity"}, "source": 34, "target": 30, "key": "6b142c7f05bcf8228991525805ee746c035e8bcd9bd209933f79c62cf988882c47a876fcd8aaab79a9361d1eb525010cc140965ebb93f3c86292c848e99c3fb3"}, {"line": 6, "relation": "decreases", "evidence": "The A (2A) receptor independence of MAO-B inhibition by CSC was further supported by the similarity of brain MAO activities derived from A (2A) receptor knockout and wild-type mice and was confirmed by demonstrating potent inhibition of A (2A) receptor kn", "citation": {"type": "PubMed", "reference": "12130655"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"ebfd5e87-2596-4d0e-b7b1-c4882a5b362b": true}, "INDRA_Belief": {"0.92": true}, "INDRA_API": {"reach": true}}, "object": {"modifier": "Activity"}, "source": 7, "target": 30, "key": "d43d2e448d1c71efb66f0c81f919b687ff5c80d9550bd4d60153e8d634f4a6cdc628f531c385eca2110be42b8b7c852ef55f13e21317538d04e95bc8971b505c"}, {"line": 7, "relation": "decreases", "evidence": "The A(2A) receptor independence of MAO-B inhibition by CSC was further supported by the similarity of brain MAO activities derived from A(2A) receptor knockout and wild-type mice and was confirmed by demonstrating potent inhibition of A(2A) receptor knock", "citation": {"type": "PubMed", "reference": "12130655"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"7898cd25-c040-4299-839d-719e68bad4f3": true}, "INDRA_Belief": {"0.65": true}, "INDRA_API": {"sparser": true}}, "object": {"modifier": "Activity"}, "source": 7, "target": 30, "key": "4b9816647be122c1ca384cbe8149b672e79bff655e2fd3ce3755d9f1f26f7ad3661124bb8cbcfcd55ec6fc8d9088ed240aaa6d7b79785933e91fdd43029c9ecb"}, {"line": 58, "relation": "decreases", "evidence": "As mentioned in the introduction, CSC is not only A 2A receptor antagonist, but also effectively inhibits MAO-B activity.", "citation": {"type": "PubMed", "reference": "22407500"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"ebfd5e87-2596-4d0e-b7b1-c4882a5b362b": true}, "INDRA_Belief": {"0.92": true}, "INDRA_API": {"reach": true}}, "object": {"modifier": "Activity"}, "source": 7, "target": 30, "key": "8917ed70b1e99d2f35da2adaa95862bf847f57c4a883144b802b6d68500649dacae9a80826dffbc42d4c745d26d134fa2282400290b346dfb09eb5f313e82748"}, {"line": 10, "relation": "decreases", "evidence": "MPP also inhibits MAO-B but noncompetitively with the substrate and with higher Ki value than that for MAO-A ().", "citation": {"type": "PubMed", "reference": "14697876"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"52ec6620-6ef0-4596-84d3-460261cd494f": true}, "INDRA_Belief": {"0.65": true}, "INDRA_API": {"sparser": true}}, "object": {"modifier": "Activity"}, "source": 32, "target": 30, "key": "7ab802311e9f6e4ebe51488b994915be1ad58039019178d571b7f7fe3fd0605756b0520548c1bb0c58bf1b3f1ad5ee61e861ae655ab019dd0609ee86acfac697"}, {"line": 11, "relation": "decreases", "evidence": "CPZ at concentrations of 5x10 (-3), 2.5 x10 (-3), 1x10 (-3) M inhibited rat brain mitochondrial MAO-B activity in vitro by 83, 55, 39%, respectively, while IMI at concentrations of 5x10 (-4), 2.5 x10 (-4), 1x10 (-4) M inhibited the in vitro enzyme activit", "citation": {"type": "PubMed", "reference": "15462192"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"824f0cef-f9b8-4eaa-8fec-79e6bd99e479": true}, "INDRA_Belief": {"0.65": true}, "INDRA_API": {"reach": true}}, "object": {"modifier": "Activity"}, "source": 19, "target": 30, "key": "fb05815ae3b4fa92cd2641ad96b227e5df9ef25499a94cf9dc66e5f51dc00a34ffb2d610aea79d298c9d57812509b4a7634b6ff2e862e2fec6767d4cd5f1ef4f"}, {"line": 12, "relation": "decreases", "evidence": "Both CSCs also inhibited glioma MAO-A and MAO-B [1.4.3.4].", "citation": {"type": "PubMed", "reference": "15527873"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"8c1fd7ae-f584-4ab4-aa82-29bc190bf3fd": true}, "INDRA_Belief": {"0.65": true}, "INDRA_API": {"sparser": true}}, "object": {"modifier": "Activity"}, "source": 44, "target": 30, "key": "e6058195393f960e117dfeef7d0a6e9c9613c6e6fa27f27a69a3cb3151da0e64cd7b60c3c1191ce777b642158ca2814dfde7c7dc60afa7f61d8f1aefdcabd065"}, {"line": 52, "relation": "decreases", "evidence": "Overexpression of parkin, but not its PD linked T240R mutant or GFP, significantly lowered the mRNA levels of MAO-A and MAO-B in P001 and P002 neurons (p < 0.05, n = 4, student 's t-test, unpaired, two tailed) (XREF_FIG), as well as the activities of MAO-", "citation": {"type": "PubMed", "reference": "22314364"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"feee5b7e-4e76-4567-a43c-d8ebe50c5f7a": true}, "INDRA_Belief": {"0.65": true}, "INDRA_API": {"reach": true}}, "source": 6, "target": 30, "key": "3f6870a78a5628450e62a9871453a5b2eaed826b1bf8fc68f4a59da9b5fe2e257a53545c936a4304a3a249082387bf3c1f33a81fae600a2c874245144ce7ed92"}, {"line": 14, "relation": "increases", "evidence": "Additionally, estrogen related receptor alpha (ERRalpha) up-regulates MAO-B gene expression in breast cancer cells.", "citation": {"type": "PubMed", "reference": "16484337"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"0408ac22-2376-4621-b189-aba4b890f668": true}, "INDRA_Belief": {"0.65": true}, "INDRA_API": {"reach": true}}, "source": 23, "target": 30, "key": "09451c10e29cbfe1b741a26d2a8439845843652559c452697ae67b2a64fa065bebaab453a5bde1fe752f611bc5d284cfbfc0a654c33873ca92cabf76d13440eb"}, {"line": 15, "relation": "increases", "evidence": "We demonstrate that ERRalpha and ERRgamma up-regulate MAO-B gene activity, whereas ERalpha and ERbeta decrease stimulation in both a ligand dependent and -independent manner.", "citation": {"type": "PubMed", "reference": "16484337"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"e7d2f14e-a378-4657-9a15-24a8ba2e6961": true}, "INDRA_Belief": {"0.65": true}, "INDRA_API": {"reach": true}}, "object": {"modifier": "Activity"}, "source": 23, "target": 30, "key": "d082265bf24d5182e589b6fe2fa8397752664609e480b222015f32df203baef0dc58c4430b98fa12f46bf07490aedf5526e75c870b343e233dc330b864adb983"}, {"line": 16, "relation": "increases", "evidence": "A structure-activity-relationship (SAR) study highlighted lipophilicity as an important property modulating the MAO-B inhibition potency of 7 substituted coumarins, as shown by a linear correlation (n = 20, r (2) = 0.72) between pIC (50) and calculated lo", "citation": {"type": "PubMed", "reference": "17193252"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"c425de75-9e1d-449b-b626-670ec2dadaf5": true}, "INDRA_Belief": {"0.65": true}, "INDRA_API": {"reach": true}}, "object": {"modifier": "Activity"}, "source": 45, "target": 30, "key": "0a8c1c347bc18b5b96b3a7d5c981de985a06fa4785ec1f276186cfc68d692fa14fa3aae35f5dd6d6ca3b7cc665f1a0bc765bb29e207be134bd98f23e1897423e"}, {"line": 18, "relation": "decreases", "evidence": "STS allows the targeted inhibition of the monoamine A (MAO-A) and MAO-B isoenzymes with minimal effects on the MAO-A in the gastrointestinal and hepatic systems.", "citation": {"type": "PubMed", "reference": "17614182"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"4c9cb3a0-86fd-4e14-8acb-82246e1bc1aa": true}, "INDRA_Belief": {"0.65": true}, "INDRA_API": {"reach": true}}, "object": {"modifier": "Activity"}, "source": 42, "target": 30, "key": "1a8c1c1fb085793663d13d6a8a6e8f167d87efef589e09c3cc25d21c745f8a9140f38b83e9299653a5563de6340e31a33e763d2e6340599beb4c5fd98b8495d3"}, {"line": 19, "relation": "decreases", "evidence": "The inhibition of MAO-B by DP may have been the means by which progression of Parkinsonism was attenuated, although other mechanisms are also tenable.", "citation": {"type": "PubMed", "reference": "1801542"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"2c55fa02-46fb-45dd-aa09-f7ef0dd97e7e": true}, "INDRA_Belief": {"0.88": true}, "INDRA_API": {"sparser": true}}, "object": {"modifier": "Activity"}, "source": 21, "target": 30, "key": "f95970c00c29a6c5adbc7812e8989bef605d821bcb55d55d70b171c69a22eca56fb13e2df8341bd05805c84ba162022df67e180cb59f4e6a46cce1320913d203"}, {"line": 21, "relation": "decreases", "evidence": "MB and the related redox dyes toluidine blue O (TBO), thionine (TN), brilliant cresyl blue (BCB), and toluylene blue (TB) were reversible competitive inhibitors of both MAO-A and MAO-B and were highly selective toward MAO-A.", "citation": {"type": "PubMed", "reference": "18077577"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"da6100e4-900c-4a0f-8aee-6791e93c8bfd": true}, "INDRA_Belief": {"0.65": true}, "INDRA_API": {"reach": true}}, "object": {"modifier": "Activity"}, "source": 31, "target": 30, "key": "7ea2aa6275aea71f42eecc459464f0cea288bc238b42df8d96d54d467f0f9c16859991a7a54eaeea81435ec3f2102ba3b5b04aa65aba40fe48ca7b73ff1de6c8"}, {"line": 24, "relation": "decreases", "evidence": "In conclusion, the present study indicates that inorganic or organic Se supplementation can decrease the brain MAO-B enzyme activity in adult rats and can be accomplished by the effect of the Se antioxidation capability.", "citation": {"type": "PubMed", "reference": "18304392"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"c438ef74-8838-4727-ac0c-a7877a50218d": true}, "INDRA_Belief": {"0.65": true}, "INDRA_API": {"reach": true}}, "object": {"modifier": "Activity"}, "source": 26, "target": 30, "key": "a17b06b1b89a2a93ad4405b72214c4f226ba796b7a093a032fa10e89de547bc9705c1aa7b7ebea68b676214b774deeefff8dd02055cdd1a248da0cf156f65d76"}, {"line": 28, "relation": "increases", "evidence": "Age related increase of MAO-B was found in all four areas of the brain, and MAO-A was increased in the nbM and temporal pole.", "citation": {"type": "PubMed", "reference": "1859299"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"866d8d22-8cad-4db6-b4b4-6ed07605ec90": true}, "INDRA_Belief": {"0.65": true}, "INDRA_API": {"reach": true}}, "object": {"modifier": "Activity"}, "source": 36, "target": 30, "key": "48a7ca6e2d78bf5d08f282225f7a4b6ded3503e79d8744e441c75959aa718178b9f0e94923f6954854fc1c80e1029a8a2cc319594bc1de671c1aed43db705ee4"}, {"line": 61, "relation": "increases", "evidence": "Age related increases in MAO-B expression is associated with increases in free radical damage and reactive oxygen species (ROS) XREF_BIBR - XREF_BIBR.", "citation": {"type": "PubMed", "reference": "23326597"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"107bc4b8-1f9a-445b-a945-f77ebb86959a": true}, "INDRA_Belief": {"0.86": true}, "INDRA_API": {"reach": true}}, "source": 36, "target": 30, "key": "d7c682256e8af0122a6e91f4896d6e071eaf81e00a83bc6820a26d1847ab63f2f2e496fc6c0b07ab6b4a253c89d87f05cbef55c9d89c539c86c994ae0f55a42f"}, {"line": 29, "relation": "association", "evidence": "Inhibition of MAO-B activity using the selective inhibitor PF9601N did not reduce this cryolesion induced inflammatory response.", "citation": {"type": "PubMed", "reference": "18831059"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"cb83add5-a502-4b59-8d00-7129c3fd0c19": true}, "INDRA_Belief": {"0.65": true}, "INDRA_API": {"reach": true}}, "source": 2, "target": 30, "key": "0b19983b0634649e54a10d48d86dda1afd90ac06fcfb2af9cc01de4caa1260830c99e2dbe80022fcdfc08bffdcbb5b5ab5894bfd347e590833db0b626ef6fb60"}, {"line": 34, "relation": "increases", "evidence": "This sensitive MS based technique allowed us to examine the affects of increased MAO-B expression in a PC12 cell model on 3NT modification of alpha-synuclein, emulating what occurs during normal aging and PD and which may contribute to alpha-synuclein agg", "citation": {"type": "PubMed", "reference": "19697948"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"8604fc2d-2dca-49d0-a96a-bed364336ae0": true}, "INDRA_Belief": {"0.65": true}, "INDRA_API": {"reach": true}}, "source": 33, "target": 30, "key": "32151023e5fcb2db5c97aaff7669c285ba0bcce0de4b35309a9892bab38547e4fc1498a340cccbc8194216b78014b1fb7755e597b95d7241051ffc8e5abb2dd1"}, {"line": 35, "relation": "increases", "evidence": "alpha-Synuclein was immunopurified from PC12 cells treated with dox to induce MAO-B overexpression, dox + deprenyl (an MAO-B inhibitor), or H 2 O 2 versus control cells (no dox).", "citation": {"type": "PubMed", "reference": "19697948"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"7430f07b-293b-4b9c-8bf5-cdbf27ab4494": true}, "INDRA_Belief": {"0.65": true}, "INDRA_API": {"reach": true}}, "subject": {"modifier": "Activity"}, "source": 40, "target": 30, "key": "d90584776b493cff2df4f958870b813c6737b567a451b2a476938d725a5cde985c41ed4dcf88aa8f6db18c6d1ce41165eaae792e0b385c8fe710c5f5039d1048"}, {"line": 38, "relation": "decreases", "evidence": "Condensation products of acetaldehyde in cigarette smoke with biogenic amines inhibit the activity of monoamine oxidase type A and monoamine oxidase type B, and there is evidence that inhibition of monoamine oxidase contributes to the addictiveness of smo", "citation": {"type": "PubMed", "reference": "20554984"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"eaa8fcec-96c3-4564-b570-38fb9c832c75": true}, "INDRA_Belief": {"0.65": true}, "INDRA_API": {"reach": true}}, "object": {"modifier": "Activity"}, "source": 46, "target": 30, "key": "8a644330bd940a33b8a9b448bb84fb3c25a31e8e3e4e4b73cb773f02cfafb40334204b97d875b65e38949d8f334e62f939aa85ec37033adfcf83ed05f8528726"}, {"line": 67, "relation": "decreases", "evidence": "Prenatal MPTP administration reduced maternal striatal and also embryonal brain MAO-B activity at 24 h post treatment but did not alter the normal postnatal development of striatal MAO-A and -B activities in the offspring.", "citation": {"type": "PubMed", "reference": "2398363"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"ffa250e3-ace8-42cd-8ab4-91248d8f52dd": true}, "INDRA_Belief": {"1.0": true}, "INDRA_API": {"reach": true}}, "object": {"modifier": "Activity"}, "source": 48, "target": 30, "key": "ab39b2f7de7a94a213ee42f17bd99ec16cc535b22f18ff3ee2a1778ab78bcb83189f31a3f3908ee055d3f159262e4e4befb5ed73e31d5f6d5542819f43ed4bda"}, {"line": 47, "relation": "decreases", "evidence": "Rasagiline is a second-generation MAO-B inhibitor that selectively and irreversibly inhibits brain MAO-B, specifically designed for the treatment of PD.", "citation": {"type": "PubMed", "reference": "21935322"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"48238ac2-39dc-4d1f-8395-61b5b30d66b3": true}, "INDRA_Belief": {"0.65": true}, "INDRA_API": {"sparser": true}}, "object": {"modifier": "Activity"}, "source": 0, "target": 30, "key": "bae886466697a0ac52375858638983c123426cf0c5a4065af0a2d073f2ff4fa07313ef8b115097a56cd69ab07bf984e170347d2f2bdf6b3108bb53f086f09f3e"}, {"line": 48, "relation": "regulates", "evidence": "Finally, Smad3 might directly regulate MAO-B at the transcriptional level although this remains to be clarified.", "citation": {"type": "PubMed", "reference": "21995845"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"756cffbb-800f-4f1a-b390-f5d03d3883c4": true}, "INDRA_Belief": {"0.86": true}, "INDRA_API": {"reach": true}}, "object": {"modifier": "Activity"}, "source": 39, "target": 30, "key": "bb90e4a0f93d384acd78cfe1f5903d6e2857f47de6522d01511462811078c8ba2b40b4425be964e9ff715c70763cdc38dc36f5c54ae53a0ffa2ef6e6d2370734"}, {"line": 49, "relation": "increases", "evidence": "However, Smad3 ablation increased the MAO-B content in the VM by 38.9% (P = 0.010, Figure XREF_FIG).", "citation": {"type": "PubMed", "reference": "21995845"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"756cffbb-800f-4f1a-b390-f5d03d3883c4": true}, "INDRA_Belief": {"0.86": true}, "INDRA_API": {"reach": true}}, "object": {"modifier": "Activity"}, "source": 39, "target": 30, "key": "f7d9e002a32ffa6b2c062f272d2f9ca2222b0ca0347d2974a561b9e1c59d3f43d1588be3923c55506d74af4417abd12762f9915c5c085fec6dc8414964464206"}, {"line": 53, "relation": "decreases", "evidence": "Overexpression of parkin, but not its PD linked T240R mutant or GFP, significantly lowered the mRNA levels of MAO-A and MAO-B in P001 and P002 neurons (p < 0.05, n = 4, student 's t-test, unpaired, two tailed) (XREF_FIG), as well as the activities of MAO-", "citation": {"type": "PubMed", "reference": "22314364"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"8d11978f-1709-419f-b878-d85997986f9d": true}, "INDRA_Belief": {"0.86": true}, "INDRA_API": {"reach": true}}, "source": 35, "target": 30, "key": "d9becf040aed1971764f9cf562e9463f1511851496371d203f0b9eb344c3ff190cd3747c63f7547f30ab95ab252812786ca945577a60f766e0a7ff0fc2fddc48"}, {"line": 57, "relation": "increases", "evidence": "These Pet-1 mutant precursors also fail to induce Tph2, Aadc, Sert, Vmat2, and Maob and therefore, Pet-1 is required for induction of all of the genes in the serotonergic-type gene battery (XREF_FIG).", "citation": {"type": "PubMed", "reference": "22366757"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"ded2d41e-7a44-4238-893f-4e3a8d46f76a": true}, "INDRA_Belief": {"0.65": true}, "INDRA_API": {"reach": true}}, "object": {"modifier": "Activity"}, "source": 25, "target": 30, "key": "9b2d36603f2e2beb3d64a2d42179dd72e7ed666cd60b135ed3602343bbbde0fa34ebd0550bd44c4f22f08adb8035ca4881920d9dc779ddbfb6aa8fa0f6fe8140"}, {"relation": "hasVariant", "source": 24, "target": 25, "key": "61b785d11bc32ecc0d387b39eca3d7384b6c70fb944211a18b703e58bc68abf94cda9b9fcbafbf4e19674f86cf3cfb5ff5d0bcc784c104134a924a2e9f6a225c"}, {"line": 59, "relation": "decreases", "evidence": "However, MAO-B was inhibited by VA in a noncompetitive and irreversible manner with an enzyme-inhibitor dissociation constant (K (i) value) of 32 nM and IC(50) equals to 19 nM.", "citation": {"type": "PubMed", "reference": "22467201"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"32ffe7f9-4089-4a2f-a359-cc6463d7f56c": true}, "INDRA_Belief": {"0.65": true}, "INDRA_API": {"sparser": true}}, "object": {"modifier": "Activity"}, "source": 50, "target": 30, "key": "d79ee0f74b314d2dec642a12cedd3ce58177cdf12da45b60589aaed6898dea47c9c94ac2fcd5daa28c40348e23eb829b7ac25aa59585f0adb0c66aa55c8f9224"}, {"line": 60, "relation": "increases", "evidence": "In addition, CAS also increased the mRNA levels of MAOB, an enzyme for dopamine degradation, in the same brain regions.", "citation": {"type": "PubMed", "reference": "23208077"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"e430dfdc-62d7-414d-949c-24153e701a01": true}, "INDRA_Belief": {"0.65": true}, "INDRA_API": {"reach": true}}, "source": 20, "target": 30, "key": "49761f9b5e95216d2b93c8e7c50062fe3c270099a5ae590fd504ac1b413a3745eba1a3ba05f61d82217e544752a81f4bb15993fac271ff7c8fcd87b2f05e98ae"}, {"line": 65, "relation": "increases", "evidence": "Thus, MAO-A and MAO-B are both expressed in the mouse aorta, induced by in vivo lipopolysaccharide and angiotensin II treatment and contribute via the generation of H (2) O (2) to endothelial dysfunction in vascular disease models.", "citation": {"type": "PubMed", "reference": "23670301"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"e481e19c-47c0-43bf-9ddd-2f7851f74934": true}, "INDRA_Belief": {"0.65": true}, "INDRA_API": {"reach": true}}, "source": 15, "target": 30, "key": "6d7eda6e767dff650e9834438db8f83283591ffc2293f4119f6fc6ca696d774a2e15946bc7b788269a9121aba2fe4a28712335dd0fc9eee13b33a45e603e1d4a"}, {"line": 69, "relation": "decreases", "evidence": "Otherwise, the results of the present study showed that the inhibition of MAO-B by all MPCs was fully reversible.", "citation": {"type": "PubMed", "reference": "24300193"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"10c34615-a1ae-45ae-b40b-7b350668cfb1": true}, "INDRA_Belief": {"0.86": true}, "INDRA_API": {"sparser": true}}, "object": {"modifier": "Activity"}, "source": 49, "target": 30, "key": "c67a903db01fc73073f67f4844ebf7a3a3a3eaf534f480ccb10a68cbfe51ab1b12fef7aad114745bd875bfcce6bb724e5e35d53878ffd38d2f7a8fb340664aba"}, {"line": 70, "relation": "decreases", "evidence": "The data showed that the inhibition of MAO-B by all studied MPCs was the non-competitive type.", "citation": {"type": "PubMed", "reference": "24300193"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"10c34615-a1ae-45ae-b40b-7b350668cfb1": true}, "INDRA_Belief": {"0.86": true}, "INDRA_API": {"sparser": true}}, "object": {"modifier": "Activity"}, "source": 49, "target": 30, "key": "7e746fc0012837d1c6f076aa1d44d80dcfa3715b19e827da9e2f9ec96dbe372889bb7c71176743952df3a1a4cc82cd1966cf71f68238ffb48b55af12b926382a"}, {"line": 71, "relation": "decreases", "evidence": "Biochemical assays revealed that administration of insulin attenuated STZ treated diabetes induced neurochemical alterations as indicated by elevated serotonin levels and decreased MAO-A and MAO-B activities in the brain.", "citation": {"type": "PubMed", "reference": "24582678"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"a25d724c-4a53-47d7-b773-5373f025f194": true}, "INDRA_Belief": {"0.65": true}, "INDRA_API": {"reach": true}}, "object": {"modifier": "Activity"}, "source": 27, "target": 30, "key": "e5f2f77333f558675fd028fed200372b42fcc97a240e4b15576f99da8b0a49ffbcccfc755b202ad321ab6d7b8ed1ce956c72e176a6e2870b049b57d75df71401"}, {"line": 72, "relation": "decreases", "evidence": "Biochemical assays revealed that administration of insulin attenuated STZ treated diabetes induced neurochemical alterations as indicated by elevated serotonin levels and decreased MAO-A and MAO-B activities in the brain.", "citation": {"type": "PubMed", "reference": "24582678"}, "annotations": {"Curator": {"NaN": true}, "Confidence": {"Medium": true}, "INDRA_UUID": {"9e8ab21d-5914-42b3-88e7-0c0a3464f851": true}, "INDRA_Belief": {"0.65": true}, "INDRA_API": {"reach": true}}, "object": {"modifier": "Activity"}, "source": 41, "target": 30, "key": "1854c4fdb7851a602355dcc10022282dddfb533012b4613a1739e9a1e8a259f2b80fb7c8b7cb59f47a88aaebe836929a336630f149e9e6fa91905bc2c7447c4c"}]}